To examine whether JKD6159-gD could activate gDT-2 CD4+ T cells in vivo, CFSE labelled congenically marked (CD45.1+) gDT-2 T cells were transferred into C57BL/6 (CD45.2) mice prior to intranasal JKD6159-gD infection. This evidence concerns the gene CD4 and infection.